Clinical Trial Update: Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial update evaluating the safety and lung function effects of repeat inhaled doses of GW597901X in asthmatic subjects, with the study status listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW597901X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED